(-)-Epicatechin is associated with increased angiogenic and mitochondrial signalling in the hindlimb of rats selectively bred for innate low running capacity

Clinical Science

Volumn 124, Issue 11, 2013, Pages 663-674

  Hüttemann, Maik ^a   Lee, Icksoo ^a   Perkins, Guy A ^b   Britton, Steven L ^c   Koch, Lauren G ^c   Malek, Moh H ^a,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

Dark chocolate; Epicatechin; Natural compound; Nutrition; Supplementation

Indexed keywords

EPICATECHIN; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MYOCYTE ENHANCER FACTOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; SYNAPTOPHYSIN; THROMBOSPONDIN 1; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HINDLIMB; IN VITRO STUDY; MALE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MORPHOMETRICS; NONHUMAN; PLANTARIS MUSCLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIGENS, CD36; ANTIGENS, CD47; CAPILLARIES; CATECHIN; ENERGY METABOLISM; HINDLIMB; KINETICS; MADS DOMAIN PROTEINS; MALE; MAP KINASE KINASE 3; MAP KINASE KINASE 6; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; MUSCLE, SKELETAL; MYOGENIC REGULATORY FACTORS; PHOSPHORYLATION; PHYSICAL ENDURANCE; RATS; RNA-BINDING PROTEINS; RUNNING; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84874684795     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120469     Document Type: Article

References (60)

1. Wagner, P. D. (1996) Determinants of maximal oxygen transport and utilization. Annu. Rev. Physiol. 58, 21-50
2. Handschin, C., Chin, S., Li, P., Liu, F., Maratos-Flier, E., Lebrasseur, N. K., Yan, Z. and Spiegelman, B. M. (2007) Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J. Biol. Chem. 282, 30014-30021
3. Pogozelski, A. R., Geng, T., Li, P., Yin, X., Lira, V. A., Zhang, M., Chi, J. T. and Yan, Z. (2009) p38γ mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice. PLoS ONE 4, e7934
4. Ḧuttemann, M., Lee, I. and Malek, M. H. (2012) (-)-Epicatechin maintains endurance training adaptation in mice after 14 days of detraining. FASEB J. 26, 1413-1422
5. Malek, M. H. and Olfert, I. M. (2009) Global deletion of thrombospondin-1 increases cardiac and skeletal muscle capillarity and exercise capacity in mice. Exp. Physiol. 94, 749-760
6. Olfert, I. M., Howlett, R. A., Wagner, P. D. and Breen, E. C. (2010) Myocyte vascular endothelial growth factor is required for exercise-induced skeletal muscle angiogenesis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R1059-R1067
7. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H. et al. (2008) AMPK and PPARδ agonists are exercise mimetics. Cell 134, 405-415
8. Jackson, J. R., Ryan, M. J. and Alway, S. E. (2011) Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J. Gerontol., Ser. A 66, 751-764
9. Kleiner, S., Nguyen-Tran, V., Bare, O., Huang, X., Spiegelman, B. and Wu, Z. (2009) PPARδ agonism activates fatty acid oxidation via PGC-1α but does not increase mitochondrial gene expression and function. J. Biol. Chem. 284, 18624-18633
10. Nogueira, L., Ramirez-Sanchez, I., Perkins, G. A., Murphy, A., Taub, P. R., Ceballos, G., Villarreal, F. J., Hogan, M. C. and Malek, M. H. (2011) (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J. Physiol. 589, 4615-4631
11. Baba, S., Osakabe, N., Natsume, M., Muto, Y., Takizawa, T. and Terao, J. (2001) Absorption and urinary excretion of (-)-epicatechin after administration of different levels of cocoa powder or (-)-epicatechin in rats. J. Agric. Food Chem. 49, 6050-6056
12. Abrahamse, S. L., Kloots, W. J. and van Amelsvoort, J. M. M. (2005) Absorption, distribution, and secretion of epicatechin and quercetin in the rat. Nut. Res. 25, 305-317
13. Koch, L. G. and Britton, S. L. (2001) Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol. Genomics 5, 45-52
14. Wisloff, U., Najjar, S. M., Ellingsen, O., Haram, P. M., Swoap, S., Al-Share, Q., Fernstrom, M., Rezaei, K., Lee, S. J., Koch, L. G. and Britton, S. L. (2005) Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307, 418-420
15. Naples, S. P., Borengasser, S. J., Rector, R. S., Uptergrove, G. M., Morris, E. M., Mikus, C. R., Koch, L. G., Britton, S. L., Ibdah, J. A. and Thyfault, J. P. (2010) Skeletal muscle mitochondrial and metabolic responses to a high-fat diet in female rats bred for high and low aerobic capacity. Appl. Physiol. Nutr. Metab. 35, 151-162
16. 2 uptake in rats selectively bred for endurance running capacity. J. Appl. Physiol. 93, 1265-1274
17. Howlett, R. A., Gonzalez, N. C., Wagner, H. E., Fu, Z., Britton, S. L., Koch, L. G. and Wagner, P. D. (2003) Selected contribution: skeletal muscle capillarity and enzyme activity in rats selectively bred for running endurance. J. Appl. Physiol. 94, 1682-1688
18. Howlett, R. A., Kirkton, S. D., Gonzalez, N. C., Wagner, H. E., Britton, S. L., Koch, L. G. and Wagner, P. D. (2009) Peripheral oxygen transport and utilization in rats following continued selective breeding for endurance running capacity. J. Appl. Physiol. 106, 1819-1825
19. Kivel̈a, R., Silvennoinen, M., Lehti, M., Rinnankoski-Tuikka, R., Purhonen, T., Ketola, T., Pullinen, K., Vuento, M., Mutanen, N., Sartor, M. A. et al. (2010) Gene expression centroids that link with low intrinsic aerobic exercise capacity and complex disease risk. FASEB J. 24, 4565-4574
20. Yamazaki, K. G., Taub, P. R., Barraza-Hidalgo, M., Rivas, M. M., Zambon, A. C., Ceballos, G. and Villarreal, F. J. (2010) Effects of (-)-epicatechin on myocardial infarct size and left ventricular remodeling after permanent coronary occlusion. J. Am. Coll. Cardiol. 55, 2869-2876
21. Yamazaki, K. G., Romero-Perez, D., Barraza-Hidalgo, M., Cruz, M., Rivas, M., Cortez-Gomez, B., Ceballos, G. and Villarreal, F. (2008) Short- and long-term effects of (-)-epicatechin on myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 295, H761-H767
22. Malek, M. H., Olfert, I. M. and Esposito, F. (2010) Detraining losses of skeletal muscle capillarization are associated with vascular endothelial growth factor protein expression in rats. Exp. Physiol. 85, 359-368
23. Lee, I., Ḧuttemann, M., Liu, J., Grossman, L. I. and Malek, M. H. (2012) Deletion of heart-type cytochrome c oxidase subunit 7A1 impairs skeletal muscle angiogenesis and oxidative phosphorylation. J. Physiol. 590, 5231-5243
24. Rosenblatt, J. D., Kuzon, W. M., Plyley, M. J., Pynn, B. R. and Mckee, N. H. (1987) A histochemical method for the simultaneous demonstration of capillaries and fiber type in skeletal muscle. Stain Technol. 62, 85-92
25. Hepple, R. T. and Mathieu-Costello, O. (2001) Estimating the size of the capillary-to-fiber interface in skeletal muscle: a comparison of methods. J. Appl. Physiol. 91, 2150-2156
26. Hepple, R. T. (1997) A new measurement of tissue capillarity: the capillary-to-fibre perimeter exchange index. Can. J. Appl. Physiol. 22, 11-22
27. Wong, L. E., Garland, Jr, T., Rowan, S. and Hepple, R. T. (2009) Anatomic capillarization is elevated in medial gastrocnemius muscle of mighty mini mice. J. Appl. Physiol. 106, 1660-1667
28. Snyder, G. K. (1990) Capillarity and diffusion distances in skeletal muscles in birds. J. Comp. Physiol. B 160, 583-591
29. Lee, I., Salomon, A. R., Ficarro, S., Mathes, I., Lottspeich, F., Grossman, L. I. and Ḧuttemann, M. (2005) cAMP-dependent tyrosine phosphorylation of subunit I inhibits cytochrome c oxidase activity. J. Biol. Chem. 280, 6094-6100
30. Rivas, D. A., Lessard, S. J., Saito, M., Friedhuber, A. M., Koch, L. G., Britton, S. L., Yaspelkis, III, B. B. and Hawley, J. A. (2011) Low intrinsic running capacity is associated with reduced skeletal muscle substrate oxidation and lower mitochondrial content in white skeletal muscle. Am. J. Physiol. Regul. Integr Comp. Physiol. 300, R835-R843
31. Lessard, S. J., Rivas, D. A., Stephenson, E. J., Yaspelkis, III, B. B., Koch, L. G., Britton, S. L. and Hawley, J. A. (2011) Exercise training reverses impaired skeletal muscle metabolism induced by artificial selection for low aerobic capacity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R175-R182
32. Hepple, R. T. and Vogell, J. E. (2004) Anatomic capillarization is maintained in relative excess of fiber oxidative capacity in some skeletal muscles of late middle-aged rats. J. Appl. Physiol. 96, 2257-2264
33. Waters, R. E., Rotevatn, S., Li, P., Annex, B. H. and Yan, Z. (2004) Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle. Am. J. Physiol. Cell Physiol. 287, C1342-C1348
34. Narkar, V. A., Fan, W., Downes, M., Yu, R. T., Jonker, J. W., Alaynick, W. A., Banayo, E., Karunasiri, M. S., Lorca, S. and Evans, R. M. (2011) Exercise and PGC-1α-independent synchronization of type I muscle metabolism and vasculature by ERRγ. Cell Metab. 13, 283-293
35. Olfert, I. M., Howlett, R. A., Tang, K., Dalton, N. D., Gu, Y., Peterson, K. L., Wagner, P. D. and Breen, E. C. (2009) Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J. Physiol. 587, 1755-1767
36. Olfert, I. M. and Birot, O. (2011) Importance of anti-angiogenic factors in the regulation of skeletal muscle angiogenesis. Microcirculation 18, 316-330
37. Roudier, E., Gineste, C., Wazna, A., Dehghan, K., Desplanches, D. and Birot, O. (2010) Angio-adaptation in unloaded skeletal muscle: new insights into an early and muscle type-specific dynamic process. J. Physiol. 588, 4579-4591
38. Kivela, R., Silvennoinen, M., Touvra, A. M., Lehti, T. M., Kainulainen, H. and Vihko, V. (2006) Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle. FASEB J. 20, 1570-1572
39. Kaur, S., Martin-Manso, G., Pendrak, M. L., Garfield, S. H., Isenberg, J. S. and Roberts, D. D. (2010) Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J. Biol. Chem. 285, 38923-38932
40. Isenberg, J. S., Qin, Y., Maxhimer, J. B., Sipes, J. M., Despres, D., Schnermann, J., Frazier, W. A. and Roberts, D. D. (2009) Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stress. Matrix Biol. 28, 110-119
41. Isenberg, J. S., Ridnour, L. A., Dimitry, J., Frazier, W. A., Wink, D. A. and Roberts, D. D. (2006) CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J. Biol. Chem. 281, 26069-26080
42. Isenberg, J. S., Pappan, L. K., Romeo, M. J., Abu-Asab, M., Tsokos, M., Wink, D. A., Frazier, W. A. and Roberts, D. D. (2008) Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann. Surg. 247, 180-190
43. Isenberg, J. S., Romeo, M. J., Yu, C., Yu, C. K., Nghiem, K., Monsale, J., Rick, M. E., Wink, D. A., Frazier, W. A. and Roberts, D. D. (2008) Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 111, 613-623
44. Isenberg, J. S., Shiva, S. and Gladwin, M. (2009) Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation. Nitric Oxide 21, 52-62
45. Frazier, E. P., Isenberg, J. S., Shiva, S., Zhao, L., Schlesinger, P., Dimitry, J., Abu-Asab, M. S., Tsokos, M., Roberts, D. D. and Frazier, W. A. (2011) Age-dependent regulation of skeletal muscle mitochondria by the thrombospondin-1 receptor CD47. Matrix Biol. 30, 154-161
46. Liesa, M., Borda-d'Agua, B., Medina-Gomez, G., Lelliott, C. J., Paz, J. C., Rojo, M., Palacin, M., Vidal-Puig, A. and Zorzano, A. (2008) Mitochondrial fusion is increased by the nuclear coactivator PGC-1β. PLoS ONE 3, e3613
47. Arany, Z., Lebrasseur, N., Morris, C., Smith, E., Yang, W., Ma, Y., Chin, S. and Spiegelman, B. M. (2007) The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35-46
48. Zechner, C., Lai, L., Zechner, J. F., Geng, T., Yan, Z., Rumsey, J. W., Collia, D., Chen, Z., Wozniak, D. F., Leone, T. C. and Kelly, D. P. (2010) Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab. 12, 633-642
49. Geng, T., Li, P., Okutsu, M., Yin, X., Kwek, J., Zhang, M. and Yan, Z. (2010) PGC-1α plays a functional role in exercise-induced mitochondrial biogenesis and angiogenesis but not fiber-type transformation in mouse skeletal muscle. Am. J. Physiol. Cell Physiol. 298, C572-C579
50. St-Pierre, J., Lin, J., Krauss, S., Tarr, P. T., Yang, R., Newgard, C. B. and Spiegelman, B. M. (2003) Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells. J. Biol. Chem. 278, 26597-26603
51. Acin-Perez, R., Bayona-Bafaluy, M. P., Bueno, M., Machicado, C., Fernandez-Silva, P., Perez-Martos, A., Montoya, J., Lopez-Perez, M. J., Sancho, J. and Enriquez, J. A. (2003) An intragenic suppressor in the cytochrome c oxidase I gene of mouse mitochondrial DNA. Hum. Mol. Genet. 12, 329-339
52. Piccoli, C., Scrima, R., Boffoli, D. and Capitanio, N. (2006) Control by cytochrome c oxidase of the cellular oxidative phosphorylation system depends on the mitochondrial energy state. Biochem. J. 396, 573-583
53. Villani, G. and Attardi, G. (1997) In vivo control of respiration by cytochrome c oxidase in wild-type and mitochondrial DNA mutation-carrying human cells. Proc. Natl. Acad. Sci. U.S.A. 94, 1166-1171
54. Villani, G., Greco, M., Papa, S. and Attardi, G. (1998) Low reserve of cytochrome c oxidase capacity in vivo in the respiratory chain of a variety of human cell types. J. Biol. Chem. 273, 31829-31836
55. Ḧuttemann, M., Helling, S., Sanderson, T. H., Sinkler, C., Samavati, L., Mahapatra, G., Varughese, A., Lu, G., Liu, J., Ramzan, R. et al. (2011) Regulation of mitochondrial respiration and apoptosis through cell signaling: cytochrome c oxidase and cytochrome c in ischemia/reperfusion injury and inflammation. Biochim. Biophys. Acta 1817, 598-609
56. o A. Science 272, 1136-1144
57. Zomer, E., Owen, A., Magliano, D. J., Liew, D. and Reid, C. M. (2012) The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model. BMJ 344, e3657
58. Grassi, D., Desideri, G., Necozione, S., Lippi, C., Casale, R., Properzi, G., Blumberg, J. B. and Ferri, C. (2008) Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J. Nutr. 138, 1671-1676
59. Ellinger, S., Reusch, A., Stehle, P. and Helfrich, H. P. (2012) Epicatechin ingested via cocoa products reduces blood pressure in humans: a nonlinear regression model with a Bayesian approach. Am. J. Clin. Nutr. 95, 1365-1377
60. Koch, L. G., Britton, S. L. and Wisloff, U. (2012) A rat model system to study complex disease risks, fitness, aging, and longevity. Trends Cardiovasc. Med. 22, 29-34